Health Secretary Robert F. Kennedy Jr. announced Monday that the Food and Drug Administration will begin removing the long-standing “black box ” warnings for drugs used to treat menopause.

FDA removing black box warnings from hormone therapy drugs, a turning point for menopause treatment

FDA officials have emphasized the new label will provide for more nuanced discussion between patients and doctors in evaluating whether HRT can be right for individuals.